120 related articles for article (PubMed ID: 9259184)
21. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
[TBL] [Abstract][Full Text] [Related]
23. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice.
Le Hir M; Haas C; Marino M; Ryffel B
Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962
[TBL] [Abstract][Full Text] [Related]
24. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis.
Hochegger K; Siebenhaar F; Vielhauer V; Heininger D; Mayadas TN; Mayer G; Maurer M; Rosenkranz AR
Eur J Immunol; 2005 Oct; 35(10):3074-82. PubMed ID: 16180252
[TBL] [Abstract][Full Text] [Related]
25. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
26. Anti-GBM nephritis in the mouse: role of granulocytes in the heterologous phase.
Schrijver G; Bogman MJ; Assmann KJ; de Waal RM; Robben HC; van Gasteren H; Koene RA
Kidney Int; 1990 Jul; 38(1):86-95. PubMed ID: 2385089
[TBL] [Abstract][Full Text] [Related]
27. Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats.
Kovalenko P; Fujinaka H; Yoshida Y; Kawamura H; Qu Z; El-Shemi AG; Li H; Matsuki A; Bilim V; Yaoita E; Abo T; Uchiyama M; Yamamoto T
Int Immunol; 2004 May; 16(5):625-34. PubMed ID: 15096492
[TBL] [Abstract][Full Text] [Related]
28. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
[TBL] [Abstract][Full Text] [Related]
29. On the pathogenesis of glomerulonephritis: a clinico-pathological study indicating that neutrophils attack and degrade glomerular basement membrane.
Sanders E; Davies M; Coles GA
Ren Physiol; 1980; 3(1-6):355-9. PubMed ID: 7034095
[TBL] [Abstract][Full Text] [Related]
30. The role of polymorphonuclear leucocytes in the autologous phase of nephrotoxic nephritis.
Naish PF; Thomson NM; Simpson IJ; Peters DK
Clin Exp Immunol; 1975 Oct; 22(1):102-11. PubMed ID: 765016
[TBL] [Abstract][Full Text] [Related]
31. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis.
Masaki T; Chow F; Nikolic-Paterson DJ; Atkins RC; Tesch GH
Nephrol Dial Transplant; 2003 Jan; 18(1):178-81. PubMed ID: 12480978
[TBL] [Abstract][Full Text] [Related]
33. [Protective effect of procyanidolic oligomers on the heterologous phase of glomerulonephritis induced by anti-glomerular basement membrane antibodies].
Melcion C; Verroust P; Baud L; Ardaillou N; Morel-Maroger L; Ardaillou R
C R Seances Acad Sci III; 1982 Dec; 295(12):721-6. PubMed ID: 6820305
[TBL] [Abstract][Full Text] [Related]
34. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
35. Increased susceptibility to immunologically mediated glomerulonephritis in IFN-gamma-deficient mice.
Ring GH; Dai Z; Saleem S; Baddoura FK; Lakkis FG
J Immunol; 1999 Aug; 163(4):2243-8. PubMed ID: 10438967
[TBL] [Abstract][Full Text] [Related]
36. Repopulation of murine Kupffer cells after intravenous administration of liposome-encapsulated dichloromethylene diphosphonate.
Yamamoto T; Naito M; Moriyama H; Umezu H; Matsuo H; Kiwada H; Arakawa M
Am J Pathol; 1996 Oct; 149(4):1271-86. PubMed ID: 8863675
[TBL] [Abstract][Full Text] [Related]
37. Quantitation and characterization of glomerular procoagulant activity in experimental glomerulonephritis.
Tipping PG; Worthington LA; Holdsworth SR
Lab Invest; 1987 Feb; 56(2):155-9. PubMed ID: 3807314
[TBL] [Abstract][Full Text] [Related]
38. Differing roles of CD18 and VLA-4 in leukocyte migration/activation during anti-GBM nephritis.
Wu X; Tiwari AK; Issekutz TB; Lefkowith JB
Kidney Int; 1996 Aug; 50(2):462-72. PubMed ID: 8840274
[TBL] [Abstract][Full Text] [Related]
39. Histopathology of humorally mediated anti-glomerular basement membrane (GBM) glomerulonephritis in mice.
Le Hir M
Nephrol Dial Transplant; 2004 Jul; 19(7):1875-80. PubMed ID: 15128887
[TBL] [Abstract][Full Text] [Related]
40. Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice.
Otten MA; Groeneveld TW; Flierman R; Rastaldi MP; Trouw LA; Faber-Krol MC; Visser A; Essers MC; Claassens J; Verbeek JS; van Kooten C; Roos A; Daha MR
J Immunol; 2009 Sep; 183(6):3980-8. PubMed ID: 19710463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
